IMARC Group has recently released a new research study titled “United States Digital Health Market Report by Type (Telehealth, Medical Wearables, EMR/EHR Systems, Medical Apps, Healthcare Analytics, and Others), Component (Software, Hardware, Service), and Region 2025-2033” which offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

Market Overview

The United States digital health market size reached USD 160.4 billion in 2024 and is expected to reach USD 695.2 billion by 2033, growing at a CAGR of 15.39% during 2025-2033. Growth is driven by increasing AI use for more precise diagnoses, rising chronic diseases like diabetes and cardiovascular disorders, and demand for personalized medicine. The market includes telehealth, medical wearables, EMR/EHR systems, medical apps, and healthcare analytics.

Study Assumption Years

• Base Year: 2024

• Historical Period: 2019-2024

• Forecast Period: 2025-2033

United States Digital Health Market Key Takeaways

• Current Market Size: USD 160.4 billion (2024)

• CAGR: 15.39%

• Forecast Period: 2025-2033

• Robust growth is driven by advances in telehealth, health apps, wearable gadgets, and supportive government regulations.

• Artificial intelligence and machine learning integration enhance diagnostic accuracy and personalized medicine.

• A shift toward telemedicine and virtual care fuels demand for remote healthcare solutions.

• Increasing prevalence of chronic diseases pushes demand for continuous health monitoring via digital solutions.

• Growing emphasis on personalized medicine is driving the need for genomic data analysis platforms and wearable technologies.

• Competitive landscape includes tech giants, digital health companies, and startups focusing on innovation and strategic alliances.

Sample Request Link: https://www.imarcgroup.com/united-states-digital-health-market/requestsample

United States Digital Health Market Growth Factors

The United States digital health market growth benefits significantly from growing adoption of artificial intelligence (AI) to improve diagnostic precision and efficiency. AI technologies enable healthcare providers to analyze large volumes of patient data rapidly, resulting in personalized treatment plans and early intervention. The integration of AI and machine learning (ML) also reduces administrative burdens for health workers and enhances patient outcomes. For example, in April 2024, Tris Pharma launched the Tris Digital Health platform with Braingaze to market an AI-powered ADHD diagnostic platform, signaling technological advancement in the field.

Chronic diseases such as diabetes, cardiovascular diseases, and respiratory disorders are increasingly prevalent among the U.S. population, necessitating ongoing monitoring and management. Digital health tools like wearable devices, remote patient monitoring, and mobile health apps provide real-time health data, improving disease management and reducing hospitalizations. The January 2024 introduction of LillyDirect™ by Eli Lilly & Company exemplifies digital health initiatives aimed at patients managing obesity, migraines, and diabetes, offering healthcare provider access and medication home delivery.

The growing trend toward personalized medicine, which tailors treatment to individual patient characteristics, drives demand for sophisticated digital health technologies. Platforms for genomic data analysis, wearable devices capable of continuous monitoring, and health apps collect and analyze patient-specific information enabling precise, effective care. Empatica's March 2024 launch of the FDA-approved EpiMonitor watch for seizure detection highlights innovations complementing personalized treatment. These advancements enhance treatment outcomes, reduce side effects, and cater to patient preferences.

United States Digital Health Market Segmentation

Breakup by Type:

• Telehealth: Remote healthcare services including video consultations, patient monitoring, and telepharmacy. Driven by demand for accessible care, especially chronic condition management.

• Medical Wearables: Devices like smartwatches and fitness trackers providing continuous health monitoring to aid early disease detection and management.

• EMR/EHR Systems: Not detailed in source; part of healthcare software infrastructure.

• Medical Apps: Mobile applications for health tracking, medication reminders, virtual appointments, and mental health support. Accelerated by smartphone proliferation.

• Healthcare Analytics: Not elaborated; involves data analysis to improve healthcare outcomes.

• Others

Breakup by Component:

• Software: Includes EHR systems, telehealth platforms, health information systems, and mobile apps that optimize healthcare delivery and patient care.

• Hardware: Medical devices such as wearables, thermometers, blood pressure monitors, and imaging systems that collect health data for analysis.

• Service: Consulting, implementation, maintenance, and training services essential for effective digital health technology adoption and operation.

Breakup by Region:

• Northeast: Home to leading healthcare institutions and research centers, strong adoption of EHR, telehealth, and analytics supported by robust infrastructure and regulation.

• Midwest: Growth driven by urban and rural healthcare needs with focus on telehealth expansion to improve access.

• South: Large population with rising healthcare demands, notable use of telehealth services particularly in rural areas.

• West: Technology hub including California, Washington, and Colorado, marked by innovation and adoption of AI, big data, and telemedicine.

Regional Insights

The Northeast region dominates the U.S. digital health market due to its concentration of top healthcare institutions, research centers, and technology-driven population. States such as New York, Massachusetts, and Pennsylvania lead in digital health adoption supported by advanced infrastructure and a favorable regulatory environment. This region excels in implementing electronic health records, telehealth services, and healthcare analytics, driving significant market contributions.

Ask an Analyst: https://www.imarcgroup.com/request?type=report&id=20344&flag=C

Recent Developments & News

• January 2024: Eli Lilly and Company launched LillyDirect™, a digital platform for obesity, migraine, and diabetes patient management including provider access and medication delivery.

• March 2024: Empatica released the FDA-approved EpiMonitor wearable for seizure detection with 98% accuracy.

• April 2024: Tris Pharma introduced Tris Digital Health and partnered with Braingaze to develop an AI-enhanced ADHD diagnostic platform with planned clinical trials.

• April 2024: Ralph H. Johnson VA Health Care System launched the AI-powered Next Level Personal Health Coach app for veterans.

• May 2024: Saint Luke’s Mid America Heart Institute and Story Health collaborated on a digital health program for atrial fibrillation to improve treatment and patient support.

Key Players

• Eli Lilly and Company

• Empatica

• Tris Pharma

• Braingaze

• NVIDIA

• Saint Luke’s Mid America Heart Institute

• Story Health

• Hydreight Technologies

• VS Digital Health

• DSV Global

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1-201971-6302